MVLA yields 666666.67% · PFE yields 6.13%● Live data
📍 MVLA pulled ahead of the other in Year 1
Combined, MVLA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MVLA + PFE for your $10,000?
Movella Holdings Inc. operates as a full-stack provider of integrated sensors, software, and analytics that enable the digitization of movement worldwide. The company offers Xsens motion capture hardware products, such as MVN Link, MVN Awinda, and MVN Awinda Starter; Xsens motion capture software products, including MVN Animate for entertainment applications and MVN Analyze for health and sports, and research, as well as cloud-based solutions to process and store data, and generate reports; MVN Processing to create motion capture media from a secure cloud-based platform; MVN Reports that presents kinematic data in a readable format; and Xsens Metaglove by Manus that uses high-fidelity finger tracking using sub-millimetre accurate fingertip tracking sensors. It also provides Xsens sensor modules for navigating, controlling, and detecting movement in industrial settings; and wearables comprising Movella DOT and MTw Awinda to track motion in various conditions with its body-worn sensors. In addition, the company offers Kinduct human performance platform, which includes tools to optimize athletic health and performance. It serves the entertainment, health and sports, and automation and mobility markets. The company is based in Henderson, Nevada.
Full MVLA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.